ML-9 TREATMENT OUTCOMES OF TIRABRUTINIB FOR RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN A SINGLE INSTITUTE

Recent clinical studies improved prognosis of primary central nervous system lymphoma (PCNSL) using multiple treatment reagents combined with radiation therapy. However, for recurrent and refractory cases after treatment with regimen consisting of multiple reagents, potent effective treatment has no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohka, Fumiharu, Yamaguchi, Junya, Motomura, Kazuya, Takeuchi, Kazuhito, Nagata, Yuichi, Maeda, Sachi, Nishikawa, Tomohide, Kibe, Yuji, Shimizu, Hiroki, Saito, Ryuta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719309/
http://dx.doi.org/10.1093/noajnl/vdac167.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719309/
http://dx.doi.org/10.1093/noajnl/vdac167.081

Ejemplares similares